Depression Home > Paxil CR and Premature Ejaculation
A number of conditions can be treated "off-label" with Paxil CR, and premature ejaculation is one of these conditions. Paxil CR is known to cause sexual side effects (such as delayed ejaculation). Generally, these sexual side effects are undesired. But in the case of men with premature ejaculation, the Paxil CR sexual side effects can be beneficial by helping to delay ejaculation.
Paxil CR® (paroxetine controlled release) is a prescription medication that is licensed to treat the following conditions:
- Depression (also known as major depression or clinical depression)
- Panic disorder
- Social anxiety disorder
- Premenstrual dysphoric disorder (PMDD).
Paxil CR is also sometimes used to treat premature ejaculation, though it is not approved for this use. This is known as an "off-label" use.
It is not entirely clear how Paxil CR works for premature ejaculation. Premature ejaculation is when a man uncontrollably ejaculates too soon (either before or just after sexual penetration). As with other similar antidepressants, Paxil CR is known to cause sexual side effects, including delayed ejaculation. While these sexual side effects are usually undesired, in the case of men with premature ejaculation, the Paxil CR sexual side effects can be beneficial by helping to delay ejaculation.
There are numerous conditions that can be treated off-label with Paxil CR, and premature ejaculation is one of them. Using a prescription drug off-label means using it to treat a disease or condition for which the drug has not been approved by the U.S. Food and Drug Administration (FDA). Although the FDA regulates how a medication can be advertised or promoted by the manufacturer, these regulations do not restrict a healthcare provider's ability to prescribe the medication for different conditions, in different doses, or for different lengths of time. Your healthcare provider will prescribe a medicine for off-label use when he or she feels that the medicine is appropriate for your situation.